Centene Corporation $CNC Stock Holdings Raised by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. lifted its stake in shares of Centene Corporation (NYSE:CNC) by 46.3% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 260,412 shares of the company’s stock after buying an additional 82,354 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Centene were worth $9,292,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. RFG Advisory LLC raised its stake in Centene by 19.0% during the third quarter. RFG Advisory LLC now owns 15,342 shares of the company’s stock valued at $547,000 after buying an additional 2,448 shares in the last quarter. Smartleaf Asset Management LLC raised its position in shares of Centene by 32.2% during the 3rd quarter. Smartleaf Asset Management LLC now owns 2,317 shares of the company’s stock valued at $82,000 after acquiring an additional 565 shares in the last quarter. Prime Capital Investment Advisors LLC bought a new position in Centene during the third quarter worth $202,000. Poehling Capital Management INC. boosted its holdings in Centene by 372.9% in the third quarter. Poehling Capital Management INC. now owns 95,967 shares of the company’s stock worth $3,424,000 after purchasing an additional 75,673 shares during the period. Finally, Portside Wealth Group LLC increased its stake in Centene by 49.8% during the third quarter. Portside Wealth Group LLC now owns 22,728 shares of the company’s stock valued at $811,000 after purchasing an additional 7,554 shares during the last quarter. 93.63% of the stock is owned by institutional investors.

Analysts Set New Price Targets

CNC has been the topic of a number of recent research reports. UBS Group set a $42.00 price target on shares of Centene and gave the stock a “neutral” rating in a research report on Thursday, October 30th. Barclays set a $44.00 target price on shares of Centene and gave the stock an “equal weight” rating in a report on Tuesday, November 4th. TD Cowen reaffirmed a “hold” rating on shares of Centene in a report on Friday, October 31st. Mizuho set a $47.00 price target on Centene in a report on Friday, January 9th. Finally, Wall Street Zen upgraded Centene from a “hold” rating to a “buy” rating in a research note on Saturday. Three investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $40.81.

Centene Stock Performance

Shares of NYSE CNC opened at $38.04 on Tuesday. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $66.03. The company has a market cap of $18.70 billion, a PE ratio of -2.79, a P/E/G ratio of 0.88 and a beta of 0.48. The stock has a 50 day simple moving average of $42.03 and a 200-day simple moving average of $36.07. The company has a current ratio of 1.10, a quick ratio of 1.08 and a debt-to-equity ratio of 0.87.

Centene (NYSE:CNC) last announced its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, beating the consensus estimate of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The firm had revenue of $49.73 billion for the quarter, compared to the consensus estimate of $48.41 billion. During the same quarter in the previous year, the business earned $0.80 EPS. The firm’s revenue for the quarter was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, equities research analysts forecast that Centene Corporation will post 6.86 EPS for the current year.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.